Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

Delayed Quote. Delayed  - 07/22 10:01:24 pm
23.92 USD   --.--%
07/21 With acquisition pending, St. Jude Medical's rivals 'licking thei..
07/20DJSt. Jude Medical Logs Double-Digit Sales Growth
07/13 BOSTON SCIENTIF : Elects Yoshiaki Fujimori to Board of Directors
News SummaryMost relevantAll newsSector news 

Boston Scientific Corporation : BSX, ABT, ZMH, and ETRM Under StockCallís Microscope

share with twitter share with LinkedIn share with facebook
share via e-mail
05/02/2013 | 02:00pm CEST

StockCall.com Provides Stock Research on Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc.

New York City, New York -- (May 02, 2013)

The Supreme Court, last year, upheld the Affordable Care Act (ACA), which is the biggest overhaul of the healthcare industry in decades. While the healthcare industry has generally supported ACA, some features of the act have faced criticism. One such feature is the 2.3% tax on gross U.S. sales of medical devices. Medical appliances & equipment makers say that the tax will lead to higher costs for them, hurting innovation. While the Senate voted in favor of repealing the 2.3% tax, it is unlikely that the tax will be repealed. Shares of medical appliances & equipment companies ended mostly lower on Wednesday, tracking losses in the broad market. Among the major movers were Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM). StockCall has released full comprehensive research on BSX, ABT, ZMH, and ETRM and these free technical analyses can be downloaded by signing up at


Shares of Boston Scientific Corporation fluctuated between gains and losses on Wednesday before finishing the day flat at $7.49 on volume of 12.95 million. Shares of the company have traded sideways this week. However, year-to-date, the stock has had an excellent run, jumping more than 30.70% as compared to a gain of nearly 11% for the S&P 500. BSX?s shares are currently trading nearly 5.80% below their 52-week high. Free technical analysis on BSX available by signing up at


Shares of Abbott Laboratories edged lower in Wednesday?s trading session, however, the losses were limited. The stock ended the day 0.08% lower at $36.89 on volume of 5.46 million after trading between $36.62 and $37.20. Despite the pullback, Abbott?s shares are up nearly 1.20% for the week. The stock has gained more than 18.50% so far in 2013, outperforming the S&P 500. However, shares of ABT have been struggling to break through $37.50 resistance level. The stock is currently trading well above its 50-day and 200-day moving averages. Register today and access the free research on ABT at


Zimmer Holdings Inc.?s shares also slipped in trading on Wednesday, tracking losses in the broad market. The stock closed 1.50% lower at $75.30 on volume of 617,800. Despite the pullback, the company?s shares are currently trading close to their 52-week high of $77.53. Shares of ZMH have been facing resistance at around $76.50. The stock currently has strong support at around $73. Zimmer?s shares are currently trading well above their 50-day and 200-day moving averages which suggests that market sentiment is bullish on the stock. The positive trend is further confirmed by recent volume activity. The free report on ZMH can be downloaded by signing up now at


Shares of EnteroMedics Inc. tumbled in Wednesday?s trading session after the company reported its financial results for the first quarter. The stock closed 9.59% lower at $0.868 on above average volume of 601,300 after touching an intra-day low of $0.86. Shares of ETRM are currently trading close to their 52-week low of $0.81. Year-to-date, the stock has now fallen nearly 69%. Most of the losses came in mid-February when the stock saw a huge sell-off. EnteroMedics? shares have now slipped below their 50-day moving average. Free report on ETRM can be accessed by registering at


About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at


Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST ? 01:30 pm EST)

© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
07/21 BOSTON SCIENTIFIC : $250,000 Federal Contract Awarded to Boston Scientific
07/21 With acquisition pending, St. Jude Medical's rivals 'licking their lips,' ana..
07/20DJSt. Jude Medical Logs Double-Digit Sales Growth
07/20 BOSTON SCIENTIFIC CORP : Other Events (form 8-K)
07/16 BOSTON SCIENTIFIC : Opens new centre
07/16 BOSTON SCIENTIFIC : Launches integrated facility in india
07/14 BOSTON SCIENTIFIC : Patent Issued for Implantable Devices Formed on Non-Fouling ..
07/13 BOSTON SCIENTIFIC CORP : Change in Directors or Principal Officers, Financial St..
07/13 BOSTON SCIENTIFIC : Elects Yoshiaki Fujimori to Board of Directors
07/13 BOSTON SCIENTIFIC : Medical Devices; Gastroenterology-Urology Devices; Classific..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07:56aDJPHILIPS : Profit Lifted by Health Technology Business
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/19DJINTUITIVE SURGICAL : Tops Expectations
07/19DJINTUITIVE SURGICAL : Tops Expectations
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
07/22 SetPoint Off To A Good Start In The Clinic
07/20 Boston Scientific to settle tax case with IRS for $275M
07/15 Stocks Are Not Overvalued - Cramer's Mad Money (7/14/16)
07/08 VALUATION DASHBOARD : Healthcare - Update
07/06 Sun Comes Out For Big-Cap Medtechs As Investors Seek Refuge From Market Squal..
Financials ($)
Sales 2016 8 165 M
EBIT 2016 1 813 M
Net income 2016 971 M
Debt 2016 3 944 M
Yield 2016 -
P/E ratio 2016 32,13
P/E ratio 2017 25,24
EV / Sales 2016 4,46x
EV / Sales 2017 4,05x
Capitalization 32 456 M
More Financials
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 24,9 $
Spread / Average Target 4,1%
Consensus details
EPS Revisions
More Estimates Revisions
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Keith D. Dawkins Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHILIPS0.96%24 759
ILLUMINA, INC.-21.46%22 192
More Results